Glaukos (GKOS) Insider Vesting: 3,884 Shares Earned by President & COO
Rhea-AI Filing Summary
Joseph E. Gilliam, President & COO of Glaukos Corporation (GKOS), reported a Form 4 transaction dated 09/18/2025. The filing shows 3,884 shares of common stock were acquired at no cash cost as the result of portion of a 2021 restricted stock unit award becoming earned after the company determined two operational targets were achieved. After the transaction, Mr. Gilliam beneficially owns 112,762 shares, which includes 64,547 restricted stock units still unvested and 167 shares purchased via the ESPP. Half of the newly earned shares will vest and be delivered on 09/23/2025 and the remainder in June 2026. The Form 4 was filed as an individual report.
Positive
- Operational targets were met, triggering the partial earning of a 2021 performance-based restricted stock unit award
- Clear vesting and delivery schedule disclosed: 50% on 09/23/2025 and 50% in June 2026, aiding transparency
Negative
- None.
Insights
TL;DR: Insider received earned RSUs after operational targets were met; disclosure is procedural with limited immediate market impact.
The Form 4 documents an earned portion of a long‑dated performance RSU grant from March 18, 2021 that vested in part when two operational targets were met. Reporting the acquisition of 3,884 shares at $0 reflects compensation realization rather than an open‑market purchase or sale. The filing clarifies remaining unvested RSUs (64,547) and timing for delivery, which supports transparency around executive pay outcomes and potential future share supply to the market.
TL;DR: This is a compensation vesting event converting performance RSUs into common shares; timing and amounts are clearly disclosed.
The report specifies that a performance award from 2021 was partially earned upon achievement of specified operational targets, yielding 3,884 shares that will be delivered in two tranches (50% on 09/23/2025 and 50% in June 2026). The filing also itemizes the reporting person's total beneficial ownership of 112,762 shares, including 64,547 unvested RSUs and 167 ESPP shares. For analysts modeling dilution or insider alignment, the disclosed schedule and remaining unvested balance are directly useful.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 3,884 | $0.00 | $0.00 |
Footnotes (2)
- F1. Represents shares of common stock underlying a portion of an award of restricted stock units previously granted by the Issuer on March 18, 2021, the vesting of which was subject to the Issuer's achievement of certain pre-determined operational targets over a multi-year performance period. The Compensation, Nominating & Governance Committee of the Issuer's Board of Directors determined on September 18, 2025 that two of the operational targets had been achieved. The number of shares reported herein consists of the portion of the award that was deemed earned based upon the achievement of the operational targets. 50% of the number of shares of common stock reported herein will vest and be delivered on September 23, 2025 and the remaining 50% will vest and be delivered in June 2026.
- F2. Includes 64,547 restricted stock units that have not yet vested or been delivered to the Reporting Person and 167 stock units purchased by the Reporting Person through the Issuer's Employee Stock Purchase Plan
FAQ
What did the Form 4 filed by Joseph E. Gilliam (GKOS) report?
How many restricted stock units remain unvested for the reporting person?
AI-generated analysis. How Rhea-AI works. Not financial advice.